HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis in the United States remain major public health concerns. The current disease-specific prevention approach oftentimes has led to narrow success and missed opportunities for increasing program capacity, leveraging resources, addressing social and structural determinants, and accelerating health impact—suggesting a need for greater innovation to prevent related diseases. The National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention’s Program Collaboration and Service Integration (PCSI) strategic priority aims to strengthen collaborative engagement across these disease areas and to integrate services at the client level. In this review, we articulate the 5 principles of PCSI—appropriateness, effectiveness, flexibility, accountability, and acceptability. Drawing upon these principles and published literature, we discuss the case for change that underlies PCSI, summarize advances in the field since 2007, and articulate key next steps. Although formal evaluation is needed to fully assess the health impact of PCSI, available evidence suggests that this approach is a promising tool to advance prevention goals.
Supplemental Digital Content is available in the article. Preliminary evidence and key accomplishments suggest that the Center for Disease Control’s Program Collaboration and Service Integration strategic priority is one approach worth exploring to improve the effectiveness of program implementation and service delivery.
From the *Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Atlanta, GA; and †Public Health England, Health and Wellbeing Directorate, London, UK
The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Conflict of interest statement: Conflicts of interest do not exist for any of the listed authors.
Correspondence: Kevin A. Fenton, MD, PhD, FFPH, 4th Floor, 133-155 Wellington House, Waterloo Road, London SE1 8UG, UK. E-mail: Kevin.Fenton@phe.gov.uk.
Received for publication March 22, 2013, and accepted May 23, 2013.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text, and links to the digital files are provided in the HTML text of this article on the journal’s Web site (http://www.stdjournal.com).